MedPath

Antidiabetic Potiential of Moringa and Dom Extract

Early Phase 1
Completed
Conditions
Diabetes
Interventions
Dietary Supplement: MorDom
Registration Number
NCT05898750
Lead Sponsor
Deraya University
Brief Summary

The Antidiabetic potential of Hyphaene thebaica fruits and Moringa oleifera leaves will be investigated in diabetic patients (type 2). The patients will be maintained on tea of both drugs for 6 weeks. The fasting blood glucose levels of patients will be checked on a daily basis. Other blood biomarkers will be also reported such as insulin concentration, Lipid profile, liver enzymes, c-peptide and glycated hemoglobin

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • diabetic patients type 2
Exclusion Criteria
  • liver failure
  • heart failure
  • renal failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
experimental groupMorDom-
Primary Outcome Measures
NameTimeMethod
Blood glucose level3 months

measured by fast blood test

Secondary Outcome Measures
NameTimeMethod
blood level of lipid profiletwo weeks

Blood samples were drawn to measure levels of LDL, HDL, triglycerides, total cholesterol

Liver enzymestwo weeks

Blood samples were drawn to measure levels of ALT and AST

C-peptide leveltwo weeks

Blood samples were drawn to measure fasting and postprandial levels of c-peptide

Insulin leveltwo weeks

Blood samples were drawn to measure fasting and postprandial levels of insulin

Trial Locations

Locations (1)

Soad A. Mohamad

🇪🇬

Minya, Egypt

© Copyright 2025. All Rights Reserved by MedPath